NEW YORK, NY--(Marketwire - June 12, 2008) - Mazal Plant Pharmaceuticals Inc. (PINKSHEETS: MZPP) (FRANKFURT: M9J) announced the filing of a provisional patent for its Cholesterol/HDL Investigatonal New Drug formulation. Mazal has already been issued a patent covering its original, first generation formula.
